Biotech · Private company
Haihe Biopharma Co., Ltd.
Track this companyFree. Adds Haihe Biopharma Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- GlumetinibPhase 2 · C-Met Exon 14 MutationClinicalTrials.gov · fetched Nov 12, 2026
- HH2710Phase 2 · Advanced TumorsClinicalTrials.gov · fetched Nov 12, 2026
- HH2853 TabletsPhase 2 · FL LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- CYH33Phase 1 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.PHASE1 · TERMINATED · started Sep 28, 2020ClinicalTrials.gov NCT04586335 · fetched Nov 12, 2026
- Evaluate the Safety and Clinical Activity of HH2853PHASE1_PHASE2 · RECRUITING · started Sep 8, 2020ClinicalTrials.gov NCT04390737 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced TumorsPHASE1_PHASE2 · TERMINATED · started Jan 7, 2020ClinicalTrials.gov NCT04198818 · fetched Nov 12, 2026
- Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung CancerPHASE1_PHASE2 · RECRUITING · started Jul 15, 2019ClinicalTrials.gov NCT04270591 · fetched Nov 12, 2026